Cell & Gene Analytics

Analytical Excellence for Cell & Gene Therapy Products

ProtaGene is a CRO leading the industry in developing DNA/RNA and protein vector analytics, advancing gene therapy safety, gene expression analysis, integration site analysis, genetic analytics, and related bioinformatic solutions.

Talk to Our Team to Get Started

We’re well-staffed and positioned to support your most complex cell and gene therapy programs.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Industry-leading Expertise Advancing Gene Therapy Safety

We have been at the forefront of developing DNA/RNA andprotein analytics that advance gene therapy safety.

Diverse Cell and Gene Therapeutic Platform Expertise

  • bullet Created with Sketch.

    Capsid-based Vectors

    • AAVs (Multiple Serotypes and Engineered Vectors)
    • Novel Systems
    • Adenovirus
  • bullet Created with Sketch.

    Complex, Envelope Vectors

    • Lentivirus
    • Gammaretrovirus
    • Novel Viruses
  • bullet Created with Sketch.

    Non-viral Vectors

    • Polynucleotide (DNA/RNA) Formulations
    • Lipid Nanoparticles
    • Transposons
    • Plasmids
  • bullet Created with Sketch.

    Genetic Editing

    • TALEN
    • CRISPR/Cas9
    • Zinc-finger Nucleases
    • Other Systems

Why ProtaGene?

We collaborate with you to design a program customized for your molecule and the demands of your development timeline.
  • Unique development expertise in both protein and gene analytics
  • Broad single-vendor analytical offering from discovery to market
  • Significant scale of expertise & multi-region facility presence
  • Best-in-class quality, supporting robust regulatory packages
  • Reputation and delivery trusted by leading biopharma companies
  • Uniting scientific excellence and compliance to assist your ATMP development
Learn More About ProtaGene

Subscribe to Our Email List

Talk to Our Experts

Leading cell and gene therapy companies around the world trust ProtaGene’s analytical excellence, deep experience, and quality systems to accelerate and de-risk their therapeutic development programs.

Contact Us